{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:14:09Z","timestamp":1786115649732,"version":"build-2736575974"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Transient Receptor Potential (TRP) channels have gained worldwide attention for their expression and distribution in multiple human organs. Among these TRPs, Transient Receptor Potential Vanilloid (TRPV) channels play diverse physiological roles in the brain, and changes in their expression contribute to central nervous system (CNS) diseases. In a previous druggable-genome \u03b1-synuclein modifier screen, a member of the TRPV family, TRPV2, emerged as a Tier 3 ion-channel candidate, meeting directionality and conflict-score criteria, though with limited shRNA-level support. However, based on this preliminary data and the known role of TRPV2 in Ca\n                      <jats:sup>2+<\/jats:sup>\n                      entry and cellular stress responses, we decided to investigate its role in detail using experimental PD models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In the present investigation, 6-hydroxydopamine (6-OHDA) was used\n                      <jats:italic>in vivo<\/jats:italic>\n                      (Sprague Dawley rats) and\n                      <jats:italic>in vitro<\/jats:italic>\n                      (SH-SY5Y cells) to induce Parkinson\u2019s disease (PD), and its effect on TRPV2 expression was investigated. The study further involved measuring behavioral parameters using the rotarod, open field, apomorphine, and cylinder tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      6-OHDA administration induced excessive reactive oxygen species (ROS) production and increased expression of TRPV2 channels. This is also accompanied by increased intracellular calcium influx and reduces cell viability. However, Tranilast, a TRPV2 antagonist, exhibited promising neuroprotective effects in the 6-OHDA PD model by restoring tyrosine hydroxylase levels, reducing oxidative stress, and improving motor function. Also, it diminished the intracellular Ca\n                      <jats:sup>2+<\/jats:sup>\n                      influx and reduced ROS levels in the 6-OHDA-treated SH-SY5Y cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, our results suggest that TRPV2 levels are elevated in PD, and targeting TRPV2 could be a potential therapeutic approach in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fncel.2026.1896592","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:25:18Z","timestamp":1785990318000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of TRPV2-associated pathology in Parkinson\u2019s disease and therapeutic modulation using Tranilast"],"prefix":"10.3389","volume":"20","author":[{"given":"Apeksha","family":"Chunchuwar","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research","place":["Mohali, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupesh","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research","place":["Mohali, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Sunder","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research","place":["Mohali, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"140790","DOI":"10.1016\/j.ijbiomac.2025.140790","article-title":"Neuroprotective potential of ApoE-mimetic peptide (ApoEFrag) in stroke models: Neurobehavioural and mechanistic study.","volume":"304","author":"Ahmed","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11064-024-04271-0","article-title":"Neuroprotective effects of thymol and p-cymene in immobilized male rats through alterations in molecular, biochemical, histological, and behavioral parameters.","volume":"50","author":"Asle-Rousta","year":"2024","journal-title":"Neurochem. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.3390\/ijms21103459","article-title":"Impact of aging on the 6-OHDA-Induced rat model of Parkinson\u2019s disease.","volume":"21","author":"Barata-Antunes","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JPD-181525","article-title":"The amphetamine induced rotation test: A re-assessment of its use as a tool to monitor motor impairment and functional recovery in rodent models of Parkinson\u2019s disease.","volume":"9","author":"Bj\u00f6rklund","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnbeh.2013.00175","article-title":"Rodent models of Parkinson\u2019s disease: Beyond the motor symptomatology.","volume":"7","author":"Campos","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1750-1326-8-14","article-title":"Behavioral characterization of the 6-hydroxidopamine model of Parkinson\u2019s disease and pharmacological rescuing of non-motor deficits.","volume":"8","author":"Carvalho","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"B7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/jnc.14702","article-title":"Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors.","volume":"150","author":"Chen","year":"2019","journal-title":"J. Neurochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.burns.2022.03.010","article-title":"In vitro and vivo study of tranilast protects from acute respiratory distress syndrome and early pulmonary fibrosis induced by smoke inhalation.","volume":"48","author":"Cui","year":"2022","journal-title":"Burns"},{"key":"B9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","article-title":"Tranilast: A review of its therapeutic applications.","volume":"91","author":"Darakhshan","year":"2015","journal-title":"Pharmacol. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis.","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"B11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.18231\/j.ijn.2019.014","article-title":"Natural products: An emerging tool in parkinson\u2019s disease therapeutics.","volume":"5","author":"Desai","year":"2019","journal-title":"Indian J. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3389\/fnins.2020.00782","article-title":"Channels role in pain associated with neurodegenerative diseases.","volume":"14","author":"Duitama","year":"2020","journal-title":"Front. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1016\/j.bmcl.2017.07.075","article-title":"Current approaches to the treatment of Parkinson\u2019s Disease","volume":"27","author":"Ellis","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0003-2697(79)80122-0","article-title":"precise method for the determination of whole blood and plasma sulfhydryl groups.","volume":"93","author":"Ellman","year":"1979","journal-title":"Anal. Biochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.3390\/ijms23073617","article-title":"TRPV2: A key player in myelination disorders of the central nervous system.","volume":"23","author":"Enrich-Bengoa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"102347","DOI":"10.1016\/j.pupt.2025.102347","article-title":"Bispecific domain antibody attenuates airway hyperresponsiveness and pulmonary inflammation in ovalbumin-lipopolysaccharide induced asthma model by inhibiting IL-23 and TNF-\u03b1.","volume":"88","author":"Gala","year":"2025","journal-title":"Pulm Pharmacol. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.nrl.2015.06.011","article-title":"The 6-hydroxydopamine model and parkinsonian pathophysiology: Novel findings in an older model.","volume":"32","author":"Hernandez-Baltazar","year":"2017","journal-title":"Neurologia"},{"key":"B18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.tiv.2017.07.030","article-title":"Comparison of different in vitro cell models for the assessment of pesticide-induced dopaminergic neurotoxicity.","volume":"45","author":"Heusinkveld","year":"2017","journal-title":"Toxicol. In Vitro"},{"key":"B19","doi-asserted-by":"publisher","first-page":"834","DOI":"10.5455\/njppp.2018.8.1249105022018","article-title":"Investigation of the antioxidant activity of hesperidin against 6-hydroxydopamine-induced cell damage in Sh-Sy5Y cells.","volume":"8","author":"Jahanshahi","year":"2018","journal-title":"Natl. J. Physiol. Pharm. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-3-642-54215-2_10","article-title":"TRPV2.","volume":"222","author":"Kojima","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/pharmaceutics13030334","article-title":"Transient receptor potential vanilloid in the brain gliovascular unit: Prospective targets in therapy.","volume":"13","author":"Luo","year":"2021","journal-title":"Pharmaceutics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41401-020-0365-y","article-title":"Recent advances in dopaminergic strategies for the treatment of Parkinson\u2019s disease","volume":"41","author":"Mao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"B23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.tiv.2016.09.015","article-title":"In vitro 6-hydroxydopamine-induced toxicity in striatal, cerebrocortical and hippocampal slices is attenuated by atorvastatin and MK-801.","volume":"37","author":"Massari","year":"2016","journal-title":"Toxicol. In Vitro"},{"key":"B24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1248\/bpb1978.10.255","article-title":"The effect of tranilast of the generation of reactive oxygen species.","volume":"10","author":"Miyachi","year":"1987","journal-title":"J. Pharmacobiodyn."},{"key":"B25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/10799893.2012.672994","article-title":"Molecular role of catalase on oxidative stress-induced Ca(2+) signaling and TRP cation channel activation in nervous system.","volume":"32","author":"Naz\u0131ro\u011flu","year":"2012","journal-title":"J. Recept. Signal Transduct Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.bbrc.2008.04.054","article-title":"Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW264.7 macrophages.","volume":"371","author":"Pae","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.reprotox.2022.08.006","article-title":"Juvenile exposure and adult risk assessment with single versus repeated exposure of melphalan in the germ cells of male SD rat: Deciphering the molecular mechanisms.","volume":"113","author":"Panghal","year":"2022","journal-title":"Reprod. Toxicol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0202597","DOI":"10.1371\/journal.pone.0202597","article-title":"Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson\u2019s disease evaluated with multimodal MRI.","volume":"13","author":"Perlbarg","year":"2018","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/antiox9101007","article-title":"Behavioral tests in neurotoxin-induced animal models of Parkinson\u2019s disease.","volume":"9","author":"Prasad","year":"2020","journal-title":"Antioxidants"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e70008","DOI":"10.1111\/jnc.70008","article-title":"Challenges and opportunities in exploring non-motor symptoms in 6-Hydroxydopamine models of Parkinson\u2019s disease: A systematic review.","volume":"169","author":"Prates-Rodrigues","year":"2025","journal-title":"J. Neurochem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00210-023-02593-4","article-title":"Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis.","volume":"397","author":"Rihan","year":"2024","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9286","DOI":"10.1523\/JNEUROSCI.0254-18.2018","article-title":"A druggable genome screen identifies modifiers of \u03b1-Synuclein levels via a tiered cross-species validation approach.","volume":"38","author":"Rousseaux","year":"2018","journal-title":"J. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/08923973.2021.1925293","article-title":"Tranilast: A potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19.","volume":"43","author":"Saeedi-Boroujeni","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/01616412.2017.1390903","article-title":"Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson\u2019s disease: Behavioral, histological and biochemical studies.","volume":"40","author":"Sarukhani","year":"2018","journal-title":"Neurol. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1007\/s00210-024-03627-1","article-title":"The anti-dyskinetic effect of the clinic-ready mGluR2 positive allosteric modulator AZD8529 in the 6-OHDA-lesioned rat.","volume":"398","author":"Shaqfah","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","article-title":"A rotarod test for evaluation of motor skill learning.","volume":"189","author":"Shiotsuki","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"B37","doi-asserted-by":"publisher","first-page":"174861","DOI":"10.1016\/j.ejphar.2022.174861","article-title":"Intervention of 3-aminobenzamide against dextran sulphate sodium induced colitis in mice: Investigations on molecular mechanisms.","volume":"920","author":"Singla","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e70698","DOI":"10.1002\/jbt.70698","article-title":"Pharmacological targeting of PARP-1-NLRP3 inflammasome pathway in colitis-associated colorectal neoplasia: Effects of 3-aminobenzamide and olaparib.","volume":"40","author":"Singla","year":"2026","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"109480","DOI":"10.1016\/j.neuropharm.2023.109480","article-title":"Bifidobacterium breve Bif11 supplementation improves depression-related neurobehavioural and neuroinflammatory changes in the mouse.","volume":"229","author":"Sushma","year":"2023","journal-title":"Neuropharmacology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.21873\/anticanres.14311","article-title":"Tranilast inhibits TGF-\u03b21-induced epithelial-mesenchymal transition and invasion\/metastasis via the suppression of smad4 in human lung cancer cell lines.","volume":"40","author":"Takahashi","year":"2020","journal-title":"Anticancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"104783","DOI":"10.1016\/j.neuint.2020.104783","article-title":"Amelioration of diabetes-induced cognitive impairment by Transient Receptor Potential Vanilloid 2 (TRPV2) channel inhibitor: Behavioral and mechanistic study.","volume":"139","author":"Thapak","year":"2020","journal-title":"Neurochem. Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12017-021-08675-x","article-title":"Tranilast, a Transient Receptor Potential Vanilloid 2 Channel (TRPV2) inhibitor attenuates amyloid \u03b2-Induced cognitive impairment: Possible mechanisms.","volume":"24","author":"Thapak","year":"2022","journal-title":"Neuromol. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e70207","DOI":"10.1002\/jbt.70207","article-title":"HC070, a Transient Receptor Potential Canonical 5 (TRPC5) channels inhibitor ameliorated \u03b1-synuclein preformed fibrils-induced Parkinson\u2019s disease: A neurobehavioural and mechanistic study.","volume":"39","author":"Vaidya","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s12035-021-02711-4","article-title":"Pharmacological modulation of TRPM2 channels via PARP pathway leads to neuroprotection in MPTP-induced Parkinson\u2019s disease in sprague dawley rats.","volume":"59","author":"Vaidya","year":"","journal-title":"Mol. Neurobiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1021\/acschemneuro.2c00403","article-title":"Neuroprotective potential of HC070, a potent TRPC5 channel inhibitor in Parkinson\u2019s disease models: A behavioral and mechanistic study.","volume":"13","author":"Vaidya","year":"","journal-title":"ACS Chem. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mito.2023.02.003","article-title":"2-Aminoethoxydiphenyl borate ameliorates mitochondrial dysfunctions in MPTP\/MPP+ model of Parkinson\u2019s disease.","volume":"69","author":"Vaidya","year":"2023","journal-title":"Mitochondrion"},{"key":"B47","doi-asserted-by":"publisher","first-page":"7289194","DOI":"10.1155\/2020\/7289194","article-title":"Roles of TRP channels in neurological diseases.","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"313702","DOI":"10.1155\/2015\/313702","article-title":"Valproic acid neuroprotection in the 6-OHDA model of Parkinson\u2019s disease is possibly related to its anti-inflammatory and HDAC inhibitory properties.","volume":"2015","author":"Ximenes","year":"2015","journal-title":"J. Neurodegener. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/cts.12606","article-title":"Tranilast treatment attenuates cerebral ischemia-reperfusion injury in rats through the inhibition of inflammatory responses mediated by NF-\u03baB and PPARs.","volume":"12","author":"Zhuo","year":"2019","journal-title":"Clin. Transl. Sci."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2026.1896592\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:25:19Z","timestamp":1785990319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2026.1896592\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":49,"alternative-id":["10.3389\/fncel.2026.1896592"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2026.1896592","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"article-number":"1896592"}}